Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure

Agnès-Laurence Chenine, Ela Shai-Kobiler, Lisa N Steele, Helena Ong, Peter Augostini, Ruijiang Song, Sandra J Lee, Patrick Autissier, Ruth M Ruprecht, W Evan Secor, Agnès-Laurence Chenine, Ela Shai-Kobiler, Lisa N Steele, Helena Ong, Peter Augostini, Ruijiang Song, Sandra J Lee, Patrick Autissier, Ruth M Ruprecht, W Evan Secor

Abstract

Background: Individuals living in sub-Saharan Africa represent 10% of the world's population but almost 2/3 of all HIV-1/AIDS cases. The disproportionate HIV-1 infection rates in this region may be linked to helminthic parasite infections that affect many individuals in the developing world. However, the hypothesis that parasite infection increases an individual's susceptibility to HIV-1 has never been prospectively tested in a relevant in vivo model.

Methodology/principal findings: We measured whether pre-existing infection of rhesus monkeys with a parasitic worm would facilitate systemic infection after mucosal AIDS virus exposure. Two groups of animals, one consisting of normal monkeys and the other harboring Schistosoma mansoni, were challenged intrarectally with decreasing doses of R5-tropic clade C simian-human immunodeficiency virus (SHIV-C). Systemic infection occurred in parasitized monkeys at viral doses that remained sub-infectious in normal hosts. In fact, the 50% animal infectious (AID(50)) SHIV-C dose was 17-fold lower in parasitized animals compared to controls (P<0.001). Coinfected animals also had significantly higher peak viral RNA loads than controls (P<0.001), as well as increased viral replication in CD4(+) central memory cells (P = 0.03).

Conclusions/significance: Our data provide the first direct evidence that acute schistosomiasis significantly increases the risk of de novo AIDS virus acquisition, and the magnitude of the effect suggests that control of helminth infections may be a useful public health intervention to help decrease the spread of HIV-1.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Parasitologic and immunologic changes in…
Figure 1. Parasitologic and immunologic changes in rhesus macaques infected with Schistosoma mansoni.
(A) Eggs per gram feces in stool samples and percent eosinophils in blood from monkeys that were infected with S. mansoni; (B) IL-4 mRNA expression in PBMC of all S. mansoni-positive rhesus monkeys prior to exposure to SHIV-C. The ratios of IL-4 mRNA copies to mRNA copies of the housekeeping gene PDH are shown. Lines represent group medians. Statistical analysis of data in panel B was performed using the Wilcoxon rank-sum test.
Figure 2. Virology and T cell subsets…
Figure 2. Virology and T cell subsets of schistosome infected and control animals following exposure to SHIV-C.
(A) Peak vRNA loads (week 2 post-inoculation) and (B) longitudinal vRNA loads in coinfected and parasite-free monkeys. (C) CD4+ and (D) CD8+ T cells in coinfected and parasite-free monkeys. Lines in panel (A) represent group medians. For panels (B), (C) and (D), points represent group means and error bars represent standard deviations. Statistical analysis of data in panel A was performed using the Wilcoxon rank-sum test. Data in panels B–D were analyzed using repeated measures analysis and generalized estimating equations to compare the data over time for the two groups.
Figure 3. Differences in CD4 + T…
Figure 3. Differences in CD4+ T cell subsets and cell viral loads between animals with S. mansoni/SHIV-C coinfection and SHIV-C infection alone.
(A) Phenotyping strategy used to separate naïve, central memory (CM), effector memory (EM) and effector memory CD45RA+ (EMRA) T cell subsets. Percentages demonstrate T cell subsets for one of the coinfected monkeys. (B) CD4+ naïve, CM and EM in coinfected and parasite-free monkeys. (C) SHIV-C RNA detected in CD4+ naïve, CM, and EM T cells after sorting. For panels (B) and (C), group means and standard deviations are represented.

References

    1. UNAIDS. AIDS Epidemic update: December 2006. 2006. Available: .
    1. Morgan D, Whitworth J. The natural history of HIV-1 infection in Africa. Nat Med. 2001;7:143–145.
    1. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 1995;16:187–191.
    1. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006;3:e102. doi:10.1371/journal.pmed.0030102.
    1. Shapira-Nahor O, Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, et al. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS. 1998;12:1731–1733.
    1. Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis. 2000;182:1804–1808.
    1. Chenine AL, Buckley KA, Li PL, Rasmussen RA, Ong H, et al. Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques. AIDS. 2005;19:1793–1797.
    1. Ayash-Rashkovsky M, Chenine AL, Steele LN, Lee SJ, Song R, et al. Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection. Infect Immun. 2007;75:1751–1756.
    1. Kallestrup P, Zinyama R, Gomo E, Butterworth AE, Mudenge B, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis. 2005;192:1956–1961.
    1. Brown M, Mawa PA, Joseph S, Bukusuba J, Watera C, et al. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Infect Dis. 2005;191:1648–1657.
    1. Lawn SD, Karanja DMS, Mwinzi P, Andove J, Colley DG, et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS. 2000;14:2437–2443.
    1. Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg. 2003;97:103–108.
    1. Song RJ, Chenine AL, Rasmussen RA, Ruprecht CR, Mirshahidi S, et al. Molecularly cloned SHIV-1157ipd3N4: a highly replication-competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. J Virol. 2006;80:8729–8738.
    1. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med. 2003;9:847–852.
    1. Hofmann-Lehmann R, Swenerton RK, Liska V, Leutenegger CM, Lutz H, et al. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses. 2000;16:1247–1257.
    1. Hofmann-Lehmann R, Williams AL, Swenerton RK, Li PL, Rasmussen RA, et al. Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection. AIDS Res Hum Retroviruses. 2002;18:627–639.
    1. Spouge JL. Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc Natl Acad Sci U S A. 1992;89:7581–7585.
    1. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–130.
    1. Chenine AL, Ferrantelli F, Hofmann-Lehmann R, Vangel MG, McClure HM, et al. Older rhesus macaque infants are more susceptible to oral infection with simian-human immunodeficiency virus 89.6P than neonates. J Virol. 2005;79:1333–1336.
    1. Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J Immunol. 1988;140:1401–1407.
    1. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science. 1995;267:1820–1825.
    1. Maggi E, Mazzetti M, Ravina A, Annunziato F, de Carli M, et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994;265:244–288.
    1. Pentaleo G, Graziosi G, Fauci AS. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328:327–335.
    1. Mwinzi PN, Karanja DM, Colley DG, Orago AS, Secor WE. Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis. 2001;184:488–496.
    1. Actor JK, Shirai M, Kullberg MC, Buller RML, Sher A, et al. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA. 1993;90:948–952.
    1. Damian RT. The exploitation of host immune responses by parasites. J Parasitol. 1987;73:3–13.
    1. McMullen DB, Ritchie LS, Oliver-Gonzalez J, Knight WB. Schistosoma mansoni in Macaca mulatta. Long-term studies on the course of primary and challenge infections. Am J Trop Med Hyg. 1967;16:620–627.
    1. Secor WE, Shah A, Mwinzi PM, Ndenga BA, Watta CO, et al. Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4+ T cells and monocytes of patients with Schistosoma mansoni infection. Infect Immun. 2003;71:6668–6671.
    1. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2:33–42.
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–656.
    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–666.

Source: PubMed

3
Předplatit